INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![how to fast track]( "Fast-Track Innovation, Address CMC Challenges In Expedited Pathways")
Fast-Track Innovation, Address CMC Challenges In Expedited PathwaysLearn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.
-
![GettyImages-1676137801 facility design, warehouse]( "Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction")
Five Ways Centralized Trial Finance Improves Site And Patient SatisfactionCentralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.
-
![GettyImages-1169621483-injection-arm-line-trial]( "Community-Focused Site Networks Increase Access And Trial Reach")
Community-Focused Site Networks Increase Access And Trial ReachCommunity-based site networks enhance clinical trial equity by engaging diverse populations, improving enrollment, retention, and developing therapies effective across varied patient groups.
-
![450_300-gettyimages_1404912467_patient__treatment__clinical]( "Why Early Medical Assessment Matters In Clinical Trials")
Why Early Medical Assessment Matters In Clinical TrialsEarly medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.
-
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials3/12/2026
Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles1/14/2026
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
Central eSource: Leveraging Site Technology2/27/2025
In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.
-
Built Like A Tech Company: Why CROs Need A New Operating System10/20/2025
See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.
-
Stipends Create More Tax Burden — Here's A Better Option7/22/2025
Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![Altasciences_CNL]( "Your Partner For Faster, More Advanced Phase 1 And 2 Trials")
Early-phase clinical research experts, specialized in first-in-human trials, clinical pharmacology/NDA-enabling studies, and proof-of-concept studies.
-
![ESG_Getty-1398247435]( "PCI Pharma Services ESG Report")
Review PCI's commitment to environmental and social responsibility, including its ambitious sustainability goals and achievements across various categories.
-
![GettyImages-944060504 coworkers computer]( "One Home for Sites™ Partnership Program Guide")
Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
-
![clinical-drug-development-GettyImages-1354172647]( "Drug Safety And Pharmacovigilance Services")
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "Clinical Trial API Integrations With TrialKit")
Enable secure, flexible data exchange with open REST integrations—streamlining workflows, reducing manual effort, and supporting modern, audit‑ready clinical operations.
